Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lung Cancer, Cervical Cancer, Cervical Cancer, Liver Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Smoking Cessation, Blood Cancer, Women's Studies, Tobacco Consumers, Kidney Cancer, Leukemia, Pancreatic Cancer, Bladder Cancer |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/29/2016 |
| Start Date: | July 2005 |
Smoking Relapse Prevention Among Postpartum Women
RATIONALE: Motivational counseling may help prevent pregnant women from smoking again after
pregnancy.
PURPOSE: This randomized clinical trial is studying three different types of counseling to
see how well they work in preventing smoking relapse after pregnancy in pregnant women who
quit smoking during pregnancy.
pregnancy.
PURPOSE: This randomized clinical trial is studying three different types of counseling to
see how well they work in preventing smoking relapse after pregnancy in pregnant women who
quit smoking during pregnancy.
OBJECTIVES:
- Develop and evaluate 2 "Motivational Relapse Prevention" (MRP) treatments of varying
intensity for reducing postpartum smoking relapse among pregnant women who quit smoking
during pregnancy.
- Assess MRP and Enhanced MRP (MRP+) effects on treatment mechanisms and the role of
those mechanisms in mediating MRP and MRP+ effects on abstinence.
- Assess the cost-effectiveness of both the MRP and MRP+ treatments relative to each
other and to usual care for reducing postpartum smoking relapse.
OUTLINE: This is a randomized study. Participants are randomized to 1 of 3 intervention
arms.
- Arm I (usual care [UC]): Participants receive self-help materials and brief relapse
prevention advice based on the Treating Tobacco Use and Dependence Clinical Practice
Guideline.
- Arm II (motivational relapse prevention [MRP]): Participants receive the same
intervention as in arm I. Participants also undergo telephone counseling over 30
minutes at 34 and 36 weeks gestation and then at 2, 4, 7, and 16 weeks postpartum.
- Arm III (enhanced MRP [MRP+]): Participants receive the same intervention as in arm I
and telephone counseling as in arm II. Participants also undergo in-person counseling
over 1 hour at 30-33 weeks gestation and then at 8 weeks postpartum.
Participants in all arms complete questionnaires at baseline, at 30-33 weeks gestation, and
then at 8 and 26 weeks postpartum.
Participants are followed at 8 and 26 weeks postpartum.
PROJECTED ACCRUAL: A total of 450 participants will be accrued for this study.
- Develop and evaluate 2 "Motivational Relapse Prevention" (MRP) treatments of varying
intensity for reducing postpartum smoking relapse among pregnant women who quit smoking
during pregnancy.
- Assess MRP and Enhanced MRP (MRP+) effects on treatment mechanisms and the role of
those mechanisms in mediating MRP and MRP+ effects on abstinence.
- Assess the cost-effectiveness of both the MRP and MRP+ treatments relative to each
other and to usual care for reducing postpartum smoking relapse.
OUTLINE: This is a randomized study. Participants are randomized to 1 of 3 intervention
arms.
- Arm I (usual care [UC]): Participants receive self-help materials and brief relapse
prevention advice based on the Treating Tobacco Use and Dependence Clinical Practice
Guideline.
- Arm II (motivational relapse prevention [MRP]): Participants receive the same
intervention as in arm I. Participants also undergo telephone counseling over 30
minutes at 34 and 36 weeks gestation and then at 2, 4, 7, and 16 weeks postpartum.
- Arm III (enhanced MRP [MRP+]): Participants receive the same intervention as in arm I
and telephone counseling as in arm II. Participants also undergo in-person counseling
over 1 hour at 30-33 weeks gestation and then at 8 weeks postpartum.
Participants in all arms complete questionnaires at baseline, at 30-33 weeks gestation, and
then at 8 and 26 weeks postpartum.
Participants are followed at 8 and 26 weeks postpartum.
PROJECTED ACCRUAL: A total of 450 participants will be accrued for this study.
Inclusion Criteria:
1. age 18 or older
2. former smoker who quit during pregnancy as assessed via self-report
3. smoked an average of greater than or equal to 1 cigarette per day during the year
prior to the current pregnancy
4. gestational age < 33 weeks and ability to attend an in-person visit at UTMDACC
between 30-33 weeks of gestational age
5. can speak, read and write in English.
6. must have a functioning home or personal cell phone
Exclusion Criteria:
1) high-risk pregnancy or known negative birth outcome
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
